Na
Posted:
June 13, 2026
Location:
Cambridge, MA, United States
Job Description
Cambridge, MA, USA | 80000-130000 per year | Full Time
Nanobiosym is an innovative nanotechnology company in Cambridge, MA, developing novel technologies to address a broad range of diseases. Nanobiosym was founded by an MIT/Harvard alum to work at the interface of physics, nanotechnology, and biomedicine. Nanobiosym was awarded the 2013 X-PRIZE- the first X-PRIZE ever awarded for healthcare.
DUTIES
+ Lead molecular diagnostic assay development in a hands-on manner through successful FDA submission
+ Manage and contribute to regulatory documents
+ Project management; personnel management skills preferred
+ Design assay performance specifications
+ Ensure assay development process meets milestones and timelines
+ Troubleshoot and solve technical issues
+ Maintain compliant laboratory documents and procedures
+ Pro-actively improve efficiency, quality and effectiveness of R & D efforts
QUA...
Nanobiosym is an innovative nanotechnology company in Cambridge, MA, developing novel technologies to address a broad range of diseases. Nanobiosym was founded by an MIT/Harvard alum to work at the interface of physics, nanotechnology, and biomedicine. Nanobiosym was awarded the 2013 X-PRIZE- the first X-PRIZE ever awarded for healthcare.
DUTIES
+ Lead molecular diagnostic assay development in a hands-on manner through successful FDA submission
+ Manage and contribute to regulatory documents
+ Project management; personnel management skills preferred
+ Design assay performance specifications
+ Ensure assay development process meets milestones and timelines
+ Troubleshoot and solve technical issues
+ Maintain compliant laboratory documents and procedures
+ Pro-actively improve efficiency, quality and effectiveness of R & D efforts
QUA...
Apply for this Job
Submit your application for the Senior Scientist: IVD Assay Developer position at Nanobiosym, Inc..
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
Cambridge, United States
Posted:
June 13, 2026
Deadline:
June 18, 2026